HC

Honasa Consumer

Q2 FY26Personal Products

Honasa Consumer Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price486
Market cap₹15.7K Cr
P/E62.2
Updated26 Aug 2026
Read4 min read

The short version

Mamaearth is back to growth with an objective of high single-digit growth in the next quarter and aims to reach double-digit growth by Q4, maintaining this into next year. Honasa Consumer expects to maintain or improve EBITDA margin around the current 7-8% range with a target to unlock 50 to 100 basis points of operating margin annually through procurement efficiencies, marketing efficiency, and product mix improvements.

From Honasa Consumer's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

  • Mamaearth is back to growth with an objective of high single-digit growth in the next quarter and aims to reach double-digit growth by Q4, maintaining this into next year.
  • Core categories' contribution expected to rise from 75% to around 84-85% over the next 4-6 quarters, driving strong share ownership.
  • Derma Co has strong growth potential with plans to build moisturizer and shampoo categories, targeting INR1,000+ crores in 1-2 years.
  • Quick commerce channel is rapidly growing, currently about 10% of revenues, with healthy economics and fastest-growing channel.
  • Total secondary sales growing well with 35% Y-o-Y increase in direct outlet billings; brand availability expanded to over 250,000 retail outlets.
  • Focus on offline expansion for brands like Derma Co, now INR100+ crores in offline run rate.
  • New brands like Lumineve in build phase targeting large long-term opportunity.
  • Overall, sustained growth backed by focus on core categories, offline distribution, and channel expansion.

Profitability & Margins

See what Honasa Consumer said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Honasa Consumer is actively investing in building new brands, focusing on mega brand creation opportunities in India driven by a new generation of consumers.
  • They have a dedicated function called the "brand factory" to cultivate and scale new brands, with openness to participation or M&A when internal bandwidth is insufficient.
  • An investment was made in Fang, an early-stage oral care brand where Honasa holds a 25% stake, with options to increase stake in the future based on performance.
  • The company emphasizes capital-efficient growth by building own brands rather than only acquiring.
  • No explicit mention of large-scale current or future capex; focus seems more on strategic brand investments and supply chain improvements.
  • Transitioning distribution from super-stockists to direct distributors is an ongoing strategic investment to improve GT reach.

Top-ranked in Personal Products

Ranked on what management guided this quarter

5x potential
1Godrej Consumer
Rev 3Mar 3
2Dabur India
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 4
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Honasa Consumer said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript from Honasa Consumer Limited's Q2 FY26 earnings call does not provide specific details on current or expected orderbook or pending orders. Key points from the available information include: - Focus on core categories driving growth rather than specific order backlog. - Emphasis on brand building and expansion into new categories and channels. - Growth driven by increased direct distribution and quick commerce channels. - No explicit mention of orderbook size or pending orders in the disclosed discussion. Thus, no quantifiable data on orderbook or pending orders is available in the provided transcript.

Honasa Consumer — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹608 Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Personal Products this season

  • Aakaar Medical (Q2 FY26)

    Long-term ambition to reach INR 1,000 crore revenue benchmark and become the number one Indian aesthetic company. Key concall takeaways from Aakaar Medical…

  • Dabur India (Q2 FY26)

    Rural growth is robust at around 7%, driven by initiatives like LUP bundles and expansion in rural distribution. Key concall takeaways from Dabur India Ltd's…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Honasa Consumer Q2 FY26 results?

Mamaearth is back to growth with an objective of high single-digit growth in the next quarter and aims to reach double-digit growth by Q4, maintaining this into next year. Honasa Consumer expects to maintain or improve EBITDA margin around the current 7-8% range with a target to unlock 50 to 100 basis points of operating margin annually through procurement efficiencies, marketing efficiency, and product mix improvements.

What is Honasa Consumer share price analysis?

Honasa Consumer currently shows a neutral. The stock trades at a P/E of 62.2 with a market cap of ₹15,711 Cr. Investors should review the full earnings analysis for detailed insights.

Is Honasa Consumer planning capital expenditure?

Honasa Consumer is actively investing in building new brands, focusing on mega brand creation opportunities in India driven by a new generation of consumers.

Keep Honasa Consumer on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.